Acceleron in advanced talks for $11B sale
Fox Business Flash top headlines for September 24
Check out what’s clicking on FoxBusiness.com.
U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
The acquisition would be made at about $180 per share in cash, the report said.
COVID VACCINE MANUFACTURER TAKING 'GO FORWARD' APPROACH TO SHOTS
Details about the potential buyer were not known, but the report added that several global drugmakers, including Bristol-Myers Squibb Co, which owns 11.5% of Acceleron's stock, are seen as potential suitors.